Intratympanic Gentamicin Therapy for Vertigo in Nonserviceable Ears
|
|
- Shanon Briggs
- 5 years ago
- Views:
Transcription
1 Intratympanic Gentamicin Therapy for Vertigo in Nonserviceable Ears Paul W. Bauer, MD, C. Bruce MacDonald, MD, and L. Clarke Cox, PhD Purpose: Intratympanic ototoxic agents have become a widely accepted means of managing vertigo in patients with Meniere s disease while preserving residual hearing. We investigated expanding the indications for intratympanic gentamicin to include control of vertigo in patients without serviceable hearing in the involved ear caused by a variety of end-organ pathologies. Materials and Methods: We present a retrospective series of 6 patients suffering from vertigo caused by end-organ disease, in an ear without serviceable hearing. Two patients suffered from delayed endolymphatic hydrops, 3from Meniere s disease, and 1 from poststapedectomy vertigo. These patients chose unilateral vestibular ablation with serial intratympanic gentamicin injection rather than labyrinthectomy for a variety of reasons. Conventional electronystagmography (ENG) testing and audiometry were completed on all patients. The ENG testing included bithermal calorics and rotational testing. All patients had a magnetic resonance image with gadolinium to exclude retrocochlear or central pathology. Rotational testing was repeated before each injection and at the conclusion of therapy to assess changes in the peripheral vestibular response. The patients subjective response to therapy was followed. Results: Follow-up has been 10 to 69 months with successful control of vertigo in all patients. Conclusions: Intratympanic gentamicin therapy offers a minimally invasive, ambulatory, low morbidity, cost-effective means of managing vertigo in patients with nonserviceable hearing. (Am J Otolaryngol 2001;22: Copyright 2001 by W.B. Saunders Company) The use of intratympanic aminoglycosides to pharmacologically ablate the vestibular system in cases of intractable vertigo was introduced by Schuknecht in He administered high doses of intratympanic streptomycin and found that ablation of the ice water caloric response was necessary to control vertigo. Unfortunately, of the 8 patients treated, all had complete loss of hearing. Schuknecht 1 concluded that vestibular function cannot be destroyed with intratympanic streptomycin without compromising hearing in the treated ear. Intratympanic aminoglycosides were reintroduced to the English literature by Beck and Schmidt 2 in They recognized that total vestibular end-organ destruction was not From the Department of Otolaryngology-Head and Neck Surgery, Boston University School of Medicine, Boston, MA. Address reprint requests to L. Clarke Cox, PhD, Department of Otolaryngology-Head and Neck Surgery, Boston Medical Center-D616, 88 East Newton Street, Boston, MA Copyright 2001 by W.B. Saunders Company /01/ $35.00/0 doi: /ajot needed to control vertigo. They advocated the use of gentamicin, as toxic effects in the secretory dark cells precede changes in the vestibular sensory neuroepithelium. Hearing loss occurred in only 15% of their 40 patients. Intratympanic gentamicin has become a widely accepted hearing conservation therapy for vertigo in Meniere s disease. Recent literature reports success in controlling vertigo in the range of 77% to 95% and unchanged or improved hearing in 62% to 80% of patients. 3-6 The range of these results appears to be related to variations in dosing regimens and the concentration of gentamicin. This literature supports the use of intratympanic gentamicin in patients with Meniere s disease who have serviceable hearing and were therefore not candidates for labyrinthectomy. In fact, a careful review of the data reveals that several studies have included some patients with nonserviceable hearing in the involved ear. 3,4,6,7 In addition, Brantberg et al 8 recently suggested expanding the indication for intratympanic gentamicin to include patients suffering from vertigo with a diagnosis other than Meniere s disease. American Journal of Otolaryngology, Vol 22, No 2 (March-April), 2001: pp
2 112 BAUER ET AL This article reports our experience in expanding the indications for intratympanic gentamicin to include control of vertigo in patients without serviceable hearing in the involved ear, caused by a variety of end-organ pathology. MATERIALS AND METHODS Data are presented on 6 patients with episodic vertigo managed with intratympanic gentamicin. Patient 1 is a 66-year-old man who had reported episodic vertigo, right aural fullness, and tinnitus for the past 30 years. After presenting to our clinic, he was managed with dietary restrictions and hydrochlorothiazide 25 mg/triamterene 37.5 mg daily for 12 months. At that point, he suffered on two occasions an otolithic crisis of Tumarkin. Patient 2 is a 52-year-old woman who originally presented with fluctuating hearing loss and acute onset of whirling vertigo. She was subsequently managed with dietary restrictions, hydrochlorothiazide 25 mg/triamterene 37.5 mg daily, and meclizine as needed for 18 months. Initially, she responded well to therapy; however, over the past 6 months she reported brief episodes of severe vertigo, fluctuating hearing loss, and left tinnitus. Patient 3 is a 48-year-old man in whom during a stapedectomy for otosclerosis the footplate apparently fell into the labyrinth and was not retrieved. He initially had good hearing as a result of his surgery. He reported complaints of slowly progressive hearing loss on the right and intermittent episodes of whirling vertigo 5.5 years after surgery. At the time an audiogram revealed a bilateral, mild, low-frequency sensorineural hearing loss (SNHL) and a right, sloping, high frequency ( 2,000 Hz) SNHL. The patient returned again 3.5 years later, now reporting that his right hearing aid no longer functioned and that his whirling vertigo now occurred more frequently. His vertigo involved transient, severe dizziness and imbalance that was quite unpredictable, not related to movement, and lasted for approximately 2 minutes. An audiogram on the left revealed a progression of his low-frequency SNHL and no response on the right. Patient 4 is a 74-year-old man who had been diagnosed with a profound, right, unilateral SNHL many years ago. He reported complaints of a several-month history of rotatory vertigo with nausea and vomiting. He was 6 months out from surgery and radiation therapy for gastric adenocarcinoma. Patient 5 is an 81-year-old man who presented with a severaldecade history of intermittent episodes of whirling vertigo, nausea, and vomiting, associated with roaring tinnitus lasting most of the day and a progressive right hearing loss. The vertigo had been managed with dietary restrictions and meclizine as needed. The patient had fallen and injured himself during a recent episode of vertigo. Patient 6 is a 42-year-old man who reported a complete loss of hearing in his left ear 25 years ago and a 5-year history of episodic vertigo and left-sided tinnitus. His vertigo had been managed with hydrochlorothiazide 25 mg/triamterene 37.5 mg daily and meclizine. Delayed endolymphatic hydrops is defined as profound unilateral or bilateral SNHL incidentally discovered in childhood or related to some specific disease process or trauma and the subsequent delayed onset of episodic vertigo. 9 Patients with Meniere s disease were diagnosed according to standard criteria. 10 The demographics of the patients with their pretherapy audiometry are summarized in Table 1. Serviceable hearing in unilateral disease was defined as a speech reception threshold of less than 50 db and a word discrimination score of more than 50%. Audiometric measurements below these were considered to represent nonserviceable hearing. Before initiating therapy, all patients underwent an initial vestibular testing battery and audiometry. The battery included conventional ENG with bithermal calorics and assessment of the vestibular ocular reflex (VOR) with rotational testing. The TABLE 1. Data From Six Patients Treated Intratympanically with Gentamicin Pt. No. Age and Gender Diagnosis Side Treated Follow-up (mos) Speech Reception Threshold (db) Word Recognition Score (%) Pure Tone Average (db) L R L R L R 1 66M MD R F MD L M PSV R NR** 100 CNT*** M DEH R M MD R CNT M DEH L 26 NR 15 CNT Abbreviations: DEH, delayed endolymphatic hydrops; MD, Meniere s disease; PSV, poststapedectomy vertigo; NR, no response; CNT, could not test.
3 GENTAMICIN THERAPY IN NONSERVICEABLE EARS 113 VOR test consisted of patient rotation around a vertical axis from 0.01 to 0.64 Hz. All patients had a magnetic resonance image with gadolinium to exclude retrocochlear or central pathology before initiating destructive, chemical ablation of the vestibular end organ. Patients were given the option of gentamicin therapy or transmastoid labyrinthectomy. These patients chose gentamicin for various reasons: Patient 1 secondary to a cardiac arrhythmia: patient 3 because of severe obstructive sleep apnea which both had a high anesthesia risk; patient 4 had inoperable gastric carcinoma and wished to avoid surgery; patient 5 was not interested in pursuing any surgical option because of his advanced age; and patients 2 and 6 were surgical candidates who chose to pursue nonsurgical therapy to avoid taking time off work. The concentration of gentamicin was 30 mg/ml in a solution buffered to a ph of 6.5. Topical phenol was used for local anesthesia before injection, with subsequent injections the hole was often still present and phenol was not needed. A total of 0.5 to 1.0 ml was injected into the middle ear space using a 25-gauge needle every other day for a total of 6 doses. After injection, the patients were asked to lay supine for 30 minutes. Patients who required repeat injections followed the same protocol but received only 3 injections. RESULTS Four patients have reported a complete resolution of their episodic vertigo during the follow-up period of 10 to 69 months. Patient 1 had a recurrence of symptoms 26 months after therapy and opted for further injections. After 3 injections, he has remained free of symptoms for 43 months. Patient 3 had a recurrence of symptoms 30 months after therapy and opted for further injections. After 3 injections, he has remained free of symptoms for 8 months. Patient 4 died from gastric carcinoma 10 months after his injections; however, he remained free of symptoms during this time. All patients have reported residual mild dysequilibrium that does not limit their normal daily activity. None of the patients required a formal vestibular rehabilitation program to achieve these results. A review of patient rotational test data revealed a change in gain after the first injection for all patients. In general, complaints of vestibular symptoms, including dysequilibrium, nausea, and vomiting were noted after the initial injection. Complaints subsided with subsequent injections. Follow-up rotary testing documented recovery of the VOR gain after treatment to approximately the baseline. DISCUSSION All of the patients in the present study had nonserviceable hearing in the involved ear. Contralateral hearing ranged from normal to mild hearing loss (Table 1). When presented with these patients in the setting of vertigo refractory to medical management, the gold standard has been destructive surgical intervention. Recent reports of a large series of patients continue to recommend labyrinthectomy to their patients with coexisting episodic vertigo and nonserviceable hearing to destroy the vestibular sensory end organ and to relieve their symptoms Although the definition of nonserviceable hearing is controversial in patients with bilateral SNHL of more than 50 db, attempts would certainly be made to aid the patient s hearing. In this study, the patients all had unilateral disease with adequate hearing in the contralateral ear. Future advances in digital and biomedical technology may redefine the concept of nonserviceable hearing. Regardless, intratympanic gentamicin can continue to spare residual cochlear function while providing effective vestibular ablation. 2-7 Two of our patients were diagnosed with delayed endolymphatic hydrops. Other investigators advocate transmastoid labyrinthectomy or translabyrinthine cochleovestibular neurectomy for delayed endolymphatic hydrops which is refractory to traditional medical management. 9,13,14 A recent report describes the use of intratympanic gentamicin to treat vertigo in 5 patients with peripheral vestibular disorders other than Meniere s disease. 8 The detailed case descriptions for 3 of these patients is highly characteristic of delayed endolymphatic hydrops and is the first report of intratympanic gentamicin being utilized for a process other than Meniere s disease. Our study represents a group of patients treated with intratympanic gentamicin who had nonserviceable hearing in the involved ear. Of these, 3 had a diagnosis other than Meniere s disease. In this way, the data have the inherent bias of representing a select
4 114 BAUER ET AL group of patients and not all of the patients treated with intratympanic gentamicin at our institution. It does show the potential for expanding the indications for its use. Intratympanic gentamicin therapy is not disease specific, but rather is pathophysiology specific. Any disease process that, as an end result, develops vertigo secondary to end-organ disease is amenable to intratympanic gentamicin ablative therapy. The clinical characteristic of delayed endolymphatic hydrops that distinguishes it from Meniere s disease is that it occurs in patients with preexisting audiometric pathology. A delay of months to years usually occurs between the original insult and the development of hydrops. This finding is in contrast to Meniere s disease, in which hydrops occurs in patients with previously normal audiometric studies. Therefore, intratympanic gentamicin therapy should be effective in managing the symptoms of vertigo in patients with delayed endolymphatic hydrops, as the underlying etiology has been theorized to be secondary to either a damaged endolymphatic sac or a blocked vestibular aqueduct. Both etiologies would limit the reabsorption of endolymph and produce hydrops. In the patient with poststapedectomy vertigo, symptoms may represent an iatrogenic case of delayed endolymphatic hydrops. Advocates of labyrinthectomy in managing hydrops report complete relief or significant improvement of vertigo at a rate of 95% to 99%. 11,12,14 Patients with an uneventful postoperative course can expect a hospital stay of 2 to 4 days, with return to work in 3 to 4 weeks. 12,14 Although rare, the potential complications of a labyrinthectomy, include wound infections, postoperative dysequilibrium, minor taste abnormalities, facial nerve paralysis, cerebrospinal fluid leak, epidural hematoma, meningitis, and death. 11,13,14 This can be compared with intratympanic gentamicin therapy in managing vertigo, reporting complete relief or significant improvement at a rate of 84% to 95%. 3,4,6,7 Injections are completed on an outpatient basis, and patients generally will miss 2 or 3 days of work at the peak of postinjection dysequilibrium. 6 The potential complications of intratympanic gentamicin include hearing loss, tympanic membrane perforation, irritative spontaneous nystagmus, 15 and a temporary acute unilateral vestibular deafferentation syndrome involving vertigo, nausea, oscillopsia, and dysequilibrium. 5 Both labyrinthectomy and intratympanic gentamicin can be complicated by prolonged or permanent dysequilibrium. In our patient population with nonserviceable hearing, hearing loss would not be considered a complication and is the reason that hearing preservation surgical techniques are not discussed. It should be noted, however, that in the 2 patients with measurable speech scores no reduction was seen with treatment. This comparison has lead us to advocate the addition of intratympanic gentamicin therapy as the end point of all medical regimens before pursuing destructive surgical intervention, regardless of hearing level. The time course of our patients central compensation seems relatively short. Clinically, minimal vestibular morbidity was seen, patients had minimal disruption of their daily activities, and if they worked they were able to return to work the day after their injection. Initial VOR changes after the first injection returned to baseline during the course of therapy. Cass et al 16 reported complete compensation in 4 of their 20 patients by 7 days after vestibular nerve section. Li et al 17 reported that the compensation period following unilateral vestibular deafferentation was on average most notable by 2.6 months postoperatively. Patients appear to compensate relatively fast following gentamicin therapy. Three theoretical options are available. First, low residual function in the treated ear, as previously stated, may have allowed for significant central compensation to occur before initiating therapy. Second, the gentamicin has selective functions on the vestibular system. It was shown in an animal model that neurotoxic changes from intratympanic gentamicin affects changes in the dark cells before alterations in the sensory neuroepithelium. 18 There is histologic evidence that dark cells in the sensory epithelium of the labyrinth regulate the ionic content of endolymph. 19 The popular theory is that damage to the dark cells affects the production of endolymph, and even without total destruction of the vestibular neurosensory epithelium, provides relief of hydrops. This is believed to account for documented cases of persistent caloric response following intratympanic gentamicin
5 GENTAMICIN THERAPY IN NONSERVICEABLE EARS 115 therapy with relief of the symptoms of hydrops. 3,4,5,7 Third, slow destruction of the vestibular end organ with intratympanic gentamicin, in contrast to the immediate destruction with labyrinthectomy or nerve section, may allow the central vestibular system to compensate more effectively. No publication has reported on long-term failure rates with the use of intratympanic gentamicin. In this study, the patient sample size is small and follow-up is in the intermediate range; however, like labyrinthectomy, failures are expected. Even if symptoms of vertigo return, there is little potential harm in repeating intratympanic gentamicin therapy. Further, all therapeutic options are still available. If the patient tires of repeated injections, or if injections fail to relieve symptoms of vertigo in the future, there is no contraindication to proceeding with labyrinthectomy at that time. CONCLUSION In our series of patients with nonserviceable hearing, intratympanic gentamicin was effective in relieving vertigo. Intratympanic gentamicin therapy offers a minimally invasive, cost-effective, low-morbidity means of managing vertigo in patients with nonserviceable hearing. REFERENCES 1. Schuknecht HF: Ablation therapy in the management of Meniere s disease. Acta Otolaryngol 132:1-42, 1957 (suppl) 2. Beck C, Schmidt CL: 10 years of experience with intratympanically applied streptomycin (gentamicin) in the therapy of morbus Meniere. Arch Otorhinolaryngol 221: , Driscoll CLW, Kasperbauer JL, Facer GW, et al: Low-dose intratympanic gentamicin and the treatment of meniere s disease: Preliminary results. Laryngoscope 107: 83-89, Hirsch BE, Kamerer DB: Intratympanic gentamicin therapy for Meniere s disease. Am J Otol 18:44-51, Murofushi T, Halmagyi GM, Yavor RA: Intratympanic gentamicin in Meniere s disease: Results of therapy. Am J Otol 18:52-57, Rauch SD, Oas JG: Intratympanic gentamicin for treatment of intractable Meniere s disease: A preliminary report. Laryngoscope 107:49-55, Nedzelski JM, Chiong CM, Fradet G, et al: Intratympanic gentamicin instillation as treatment of unilateral Meniere s disease: Update of an ongoing study. Am J Otol 14: , Brantberg K, Bergenius J, Tribukait A: Gentamicin treatment in peripheral vestibular disorders other than Meniere s disease. ORL J Otorhinolaryngol Relat Spec 58: , Schuknecht HF: Delayed endolymphatic hydrops. Ann Otol Rhinol Laryngol 87: , Committee on Hearing and Equilibrium: Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere s disease. Otolaryngol Head Neck Surg 113: , Langman AW, Linderman RC: Surgery for vertigo in the nonserviceable hearing ear: Transmastoid labyrinthectomy or translabyrinthine vestibular nerve section. Laryngoscope 103: , Graham MD, Goldsmith MM: Labyrinthectomy. Indications and surgical technique. Otolaryngol Clin North Am 27: , Yazdi AK, Rutka J: Results of labyrinthectomy in the treatment of Meniere s disease and delayed endolymphatic hydrops. J Otolaryngol 25:26-31, Gacek RR, Gacek MR: Comparison of labyrinthectomy and vestibular neurectomy in the control of vertigo. Laryngoscope 106: , Parnes LS, Riddell D: Irritative spontaneous nystagmus following intratympanic gentamicin for Meniere s disease. Laryngoscope 103: , Cass SP, Kartush JM, Graham MD: Patterns of vestibular function following vestibular nerve section. Laryngoscope 102: , Li CW, Cousins V, Hooper R: Vestibulo-ocular compensation following unilateral vestibular deafferentation. Ann Otol Rhinol Laryngol 101: , Pender DJ: Gentamicin tympanoclysis: Effects on the vestibular secretory cells. Am J Otolaryngol 6: , Monsell EM, Cass SP, Rybak LP: Therapeutic use of aminoglycosides in Meniere s disease. Otolaryngol Clin North Am 26: , 1993
Delayed Endolymphatic Hydrops: Episodic Vertigo of Delayed Onset after Profound Inner Ear Hearing Loss
Delayed Endolymphatic Hydrops: Episodic Vertigo of Delayed Onset after Profound Inner Ear Hearing Loss Tamio Kamei 1, MD, PhD and Kenji Watanabe 2, MD 1 Professor emeritus at Gunma University, Japan 2
More informationMenièré s Disease. Overview. Clinical Presentation. Pathology. Intratympanic therapy. Mitchell Ramsey, MD Tripler Army Medical Center
Menièré s Disease Mitchell Ramsey, MD Tripler Army Medical Center Overview Clinical Presentation Pathology Intratympanic therapy Clinical Manifestations Classical type (1861) Vertigo, hearing loss, tinnitus,
More informationDrug delivery to the inner ear
Intratympanic Drug Delivery Society of Otorhinolaryngology and Head-Neck Nurses Advantages of intratympanic delivery Higher concentration of drug at site of action Avoid systemic effects May be able to
More informationIntratympanic Gentamicin for Intractable Ménière s Disease A Review and Analysis of Audiovestibular Impact
190 Update Article THIEME Intratympanic Gentamicin for Intractable Ménière s Disease A Review and Analysis of Audiovestibular Impact Sertaç Yetişer 1 1 Department of Otorhinolaryngology, Anadolu Saglik
More informationA patient with endolymphatic hydrops may experience any combination of the below described symptoms:
MENIERE S DISEASE Endolymphatic hydrops and Meniere s disease are disorders of the inner ear. Although the cause is unknown, it probably results from an abnormality of the fluids of the inner ear. In most
More informationVery few dizzy conditions have a surgical treatment SURGICAL MANAGEMENT OF THE DIZZY PATIENT. Surgical Treatments for. Shunts and Sac Surgery
SURGICAL MANAGEMENT OF THE DIZZY PATIENT Very few dizzy conditions have a surgical treatment Timothy C. Hain, M.D. Meniere s Disease Perilymphatic Fistula (PLF) Superior Canal Dehiscence (SSD) Benign Paroxysmal
More informationNormal membranous labyrinth. Dilated membranous labyrinth in Meniere's disease (Hydrops)
Meniere s Disease Normal membranous labyrinth Dilated membranous labyrinth in Meniere's disease (Hydrops) Normal membranous labyrinth Dilated membranous labyrinth in Meniere's disease (Hydrops) DEFINITION
More information15 Marzo 2014 Aspetti radiologici dei disordini vestibolari: approccio multidisciplinare
15 Marzo 2014 Aspetti radiologici dei disordini vestibolari: approccio multidisciplinare MR Imaging of inner ear endo-perilymphatic spaces at 3T after intratympanic contrast agent administration in Definite
More informationWhat is Meniere's disease? What causes Meniere's disease?
NIH Publication No 95-3403 November 1994 What is Meniere's disease? Meniere's disease is an abnormality of the inner ear causing a host of symptoms, including vertigo or severe dizziness, tinnitus or a
More informationIntratympanic Injections of a Pharmacologic Agent for the Treatment of Meniere s Disease or Sudden Hearing Loss. Original Policy Date
MP 2.01.47 Intratympanic Injections of a Pharmacologic Agent for the Treatment of Meniere s Disease or Sudden Hearing Loss Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last
More informationUniversity of Groningen. Definition Menière Groningen Mateijsen, Dionisius Jozef Maria
University of Groningen Definition Menière Groningen Mateijsen, Dionisius Jozef Maria IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationEffect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere s Disease
Original Article Iranian Journal of Otorhinolaryngology, Vol.26(3), Serial No.76, Jul 2014 Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere s Disease Abstract Faramarz
More informationMonitoring of Caloric Response and Outcome in Patients With Benign Paroxysmal Positional Vertigo
Otology & Neurotology 28:798Y800 Ó 2007, Otology & Neurotology, Inc. Monitoring of Caloric Response and Outcome in Patients With Benign Paroxysmal Positional Vertigo *Maria I. Molina, *Jose A. López-Escámez,
More informationManagement of Ear, Hearing and Balance Disorders: Fact, Fiction, and Future
Management of Ear, Hearing and Balance Disorders: Fact, Fiction, and Future George W. Hicks, M,D. 7440 N. Shadeland Avenue, Suite 150 Indianapolis, IN 46250 904 N. Samuel Moore Parkway Mooresville, IN
More informationMeniere s disease and Sudden Sensorineural Hearing Loss
Meniere s disease and Sudden Sensorineural Hearing Loss Tsutomu Nakashima 1,2 1 Ichinomiya Medical Treatment & Habilitation Center, Ichinomiya, Japan 2 Department of Otorhinolaryngology, Nagoya University,
More informationPage: 1 of 6. Transtympanic Micropressure Applications as a Treatment of Meniere's Disease
Page: 1 of 6 Last Review Status/Date: December 2013 as a Treatment of Meniere's Disease Description Transtympanic micropressure treatment for Meniere s disease involves use of a hand-held air pressure
More informationINTRATYMPANIC GENTAMICIN PERFUSIONS. ENDOLYMPHATIC HYDROPS (ELH, Meniere s disease)
INTRATYMPANIC GENTAMICIN PERFUSIONS ENDOLYMPHATIC HYDROPS (ELH, Meniere s disease) Risks, Complications and Post-operative Instructions The inner ear comprises a bony casing (the otic capsule), containing
More informationIntratympanic therapy of inner ear disease
Intratympanic therapy of inner ear disease Jack J. Wazen, M.D.FACS. VP & Director of Research Silverstein Institute Ear Research Foundation Sudden Sensorineural Definition Hearing Loss Sudden SNHL is defined
More informationORIGINAL CONTRIBUTION
ORIGINAL CONTRIBUTION Drop Attacks and Vertigo Secondary to a Non-Meniere Otologic Cause Gail Ishiyama, MD; Akira Ishiyama, MD; Robert W. Baloh, MD Background: Tumarkin falls are sudden drop-attack falls
More informationPeripheral vestibular disorders will affect 1 of 13 people in their lifetime
Peripheral vestibular disorders will affect 1 of 13 people in their lifetime 80% of affected persons seek medical consultation Unclear how many of these are for peripheral vs central disorders Generally:
More informationTranstympanic Micropressure Applications as a Treatment of Meniere s Disease
Transtympanic Micropressure Applications as a Treatment of Meniere s Disease Policy Number: 1.01.23 Last Review: 8/2017 Origination: 2/2006 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas
More informationClinical Characteristics and Short-term Outcomes of Acute Low Frequency Sensorineural Hearing Loss With Vertigo
Original Article Clinical and Experimental Otorhinolaryngology Vol. 11, No. 2: 96-101, June 2018 https://doi.org/10.21053/ceo.2017.00948 pissn 1976-8710 eissn 2005-0720 Clinical Characteristics and Short-term
More informationLong-Term Follow-Up of Tinnitus in Patients with Otosclerosis After Stapes Surgery
International Tinnitus Journal, Vol. 10, No.2, 197-201 (2004) Long-Term Follow-Up of Tinnitus in Patients with Otosclerosis After Stapes Surgery Pollyanna G. Sobrinho, Carlos A. Oliveira, and Alessandra
More informationCITY & HACKNEY PATHFINDER CLINICAL COMMISSIONING GROUP. Vertigo. (1) Vertigo. (4) Provisional Diagnosis. (5) Investigations. lasting days or weeks
Authors: Dr Lucy O'Rouke and Mr N Eynon-Lewis Review date: January 2017 Vertigo (1) Vertigo (2) History (3) Examination (4) Provisional Diagnosis (5) Investigations (6) Medical Cause (7) Psychiatric Cause
More informationSudden Sensorineural Hearing Loss; Prognostic Factors
Original Article Iranian Journal of Otorhinolaryngology, Vol.27(5), Serial No.82, Sep 2015 Abstract Sudden Sensorineural Hearing Loss; Prognostic Factors Dass Arjun 1, * Goel Neha 1, Singhal Surinder K
More informationHearing Function After Intratympanic Application of Gadolinium- Based Contrast Agent: A Long-term Evaluation
The Laryngoscope VC 2015 The American Laryngological, Rhinological and Otological Society, Inc. Hearing Function After Intratympanic Application of Gadolinium- Based Contrast Agent: A Long-term Evaluation
More informationIntratympanic application of gentamicin for treatment of
Keio Journal of Medicine 35: 36-41, 1986 Lecture Intratympanic application of gentamicin for treatment of Meniere's disease Chlodwig Beck Department of Otolaryngology, Freiburg University Killianstr. 5.
More informationTranstympanic Micropressure Applications as a Treatment of Meniere s Disease
Transtympanic Micropressure Applications as a Treatment of Meniere s Disease Policy Number: 1.01.23 Last Review: 8/2014 Origination: 2/2006 Next Review: 8/2015 Policy Blue Cross and Blue Shield of Kansas
More informationEndolymphatic Duct Blockage for Refractory Ménière s Disease: Assessment of Endolymphatic Sac Biopsy on Short-Term Surgical Outcomes
J Int Adv Otol 2016; 12(3): 310-5 DOI: 10.5152/iao.2016.3069 Original Article Endolymphatic Duct Blockage for Refractory Ménière s Disease: Assessment of Endolymphatic Sac Biopsy on Short-Term Surgical
More informationG. Doobe, 1 A. Ernst, 1 R. Ramalingam, 2 P. Mittmann, 1 and I. Todt Introduction. 2. Materials and Methods
BioMed Research International Volume 2015, Article ID 457318, 4 pages http://dx.doi.org/10.1155/2015/457318 Research Article Simultaneous Labyrinthectomy and Cochlear Implantation for Patients with Single-Sided
More informationBecause dizziness is an imprecise term, a major role of the clinician is to sort patients out into categories
Dizziness and Imbalance Timothy C. Hain, MD Clinical Professor of Neurology, Otolaryngology, Physical Therapy Chicago Dizziness and Hearing 645 N. Michigan, Suite 410 312-274-0197 Lecture Goals 1. What
More informationMÉNIÈRE S DISEASE (MD)
Progression of Symptoms of Dizziness in Ménière s Disease Mari Havia, MD; Erna Kentala, MD, PhD ORIGINAL ARTICLE Objective: To evaluate the progression of symptoms of dizziness in Ménière s disease (MD)
More informationOtologic (Ear) Dizziness Fistula SCD Bilateral. Other. Neuritis BPPV. Menieres
Otologic Dizziness (Dizziness from Ear) Ear Structures of importance Timothy C. Hain, MD Northwestern University, Chicago t-hain@northwestern.edu The ear is an inertial navigation device Semicircular Canals
More informationRelieve your vertigo symptoms with a simple and effective treatment for Ménière s disease
Relieve your vertigo symptoms with a simple and effective treatment for Ménière s disease Ménière s Disease Ménière s disease is a complex inner ear condition that can be unpredictable and disabling. Usually
More informationSasan Dabiri, MD, Assistant Professor
Sasan Dabiri, MD, Assistant Professor Department of Otorhinolaryngology Head & Neck Surgery Amir A lam hospital Tehran University of Medical Sciences October 2015 Outlines Anatomy of Vestibular System
More informationLabyrinth Anesthesia A Forgotten but Practical Treatment Option in Ménière s Disease
Original Paper ORL 2003;65:84 90 DOI: 10.1159/000070771 Received: February 20, 2003 Accepted: March 6, 2003 Labyrinth Anesthesia A Forgotten but Practical Treatment Option in Ménière s Disease Oliver Adunka
More informationUNILATERAL MENIERE S DISEASE; INTRA TYMPANIC INJECTION OF LOW DOSE GENTAMICIN IN THE TREATMENT
The Professional Medical Journal DOI: 10.17957/TPMJ/16.3129 ORIGINAL PROF-3129 UNILATERAL MENIERE S DISEASE; INTRA TYMPANIC INJECTION OF LOW DOSE GENTAMICIN IN THE TREATMENT 1. Professor and Consultant
More informationVestibular-Evoked Myogenic Potentials as a Test of Otolith Function
Original Paper Med Principles Pract 2002;11:136 140 Received: April 10, 2001 Accepted: March 17, 2002 Vestibular-Evoked Myogenic Potentials as a Test of Otolith Function Khalid Al-Sebeih a Anthony Zeitouni
More informationHearing fluctuation is not a predictor of vertigo attacks in Meniere s syndrome
52 Celene Mc Neill MA 1,2 William Gibson MD 3,4 Alan Taylor PhD 2 Hearing fluctuation is not a predictor of vertigo attacks in Meniere s syndrome Abstract 1 Healthy Hearing & Balnace Care, Sydney, Australia.
More informationBenign Paroxysmal Positional Vertigo (BPPV) Structures of importance. The ear is an inertial navigation device. Vestibular Reflexes
Otologic Dizziness (Dizziness from Ear) Structures of importance Timothy C. Hain, MD Northwestern University, Chicago t-hain@northwestern.edu The ear is an inertial navigation device Semicircular Canals
More informationClinical Significance of Vestibular Evoked Myogenic Potentials in Benign Paroxysmal Positional Vertigo
Otology & Neurotology 29:1162Y1166 Ó 2008, Otology & Neurotology, Inc. Clinical Significance of Vestibular Evoked Myogenic Potentials in Benign Paroxysmal Positional Vertigo *Won Sun Yang, Sung Huhn Kim,
More informationCorporate Medical Policy
Corporate Medical Policy Transtympanic Micropressure Applications as a Treatment of File Name: Origination: Last CAP Review: Next CAP Review: Last Review: transtympanic_micropressure_applications_as_a_treatment_of_menieres_disease
More informationVertigo. Definition Important history questions Examination Common vertigo cases and management Summary
Vertigo Vertigo Definition Important history questions Examination Common vertigo cases and management Summary Cases 1) 46 year old man presents two weeks after knocking his head with recurrent episodes
More informationThe Relationship Between Endolymphatic Hydrops in the Vestibule and Low-Frequency Air-Bone Gaps
The Laryngoscope VC 2017 The American Laryngological, Rhinological and Otological Society, Inc. The Relationship Between Endolymphatic Hydrops in the Vestibule and Low-Frequency Air-Bone Gaps Satofumi
More informationSpartan Medical Research Journal
Spartan Medical Research Journal Research at Michigan State University College of Osteopathic Medicine Volume 3 Number 2 Fall, 2018 Pages 113-122 Title: Correlation of Clinical Factors and Audiometric
More informationAssessing the Deaf & the Dizzy. Phil Bird Senior Lecturer University of Otago, Christchurch Consultant Otolaryngologist CPH & Private
Assessing the Deaf & the Dizzy Phil Bird Senior Lecturer University of Otago, Christchurch Consultant Otolaryngologist CPH & Private Overview Severe & profoundly deaf children & adults Neonatal screening
More informationClinical Experience in Diagnosis and Management of Superior Semicircular Canal Dehiscence in Children
The Laryngoscope VC 2011 The American Laryngological, Rhinological and Otological Society, Inc. Clinical Experience in Diagnosis and Management of Superior Semicircular Canal Dehiscence in Children Gi
More informationWindow to an Unusual Vestibular Disorder By Mark Parker
WELCOME BACK to an ongoing series that challenges the audiologist to identify a diagnosis for a case study based on a listing and explanation of the nonaudiology and audiology test battery. It is important
More informationM eniere's disease, or idiopathic endolymphatic. Intratympanic Gentamicin Treatment : Preliminary Results in Two Patients with Meniere's Disease
J Am Acad Audiol 6 : 264-270 (1995) Intratympanic Gentamicin Treatment : Preliminary esults in Two Patients with Meniere's Disease Mary Beth Trine* Susan G. ynn* George W Facert Jan. Kasperbauert Abstract
More informationSudden sensorineural hearing loss (SSNHL) is defined
Transtympanic steroids for treatment of sudden hearing loss GERARD J. GIANOLI, MD, FACS, and JOHN C. LI, MD, FACS, Baton Rouge, Louisiana, and Jupiter, Florida OBJECTIVES: To determine whether transtympanic
More informationORIGINAL ARTICLE. A New Physical Maneuver for the Treatment of Benign Paroxysmal Positional Vertigo
ORIGINAL ARTICLE Victor Vital, MD; Athanasia Printza, MD; Joseph Vital, MD; Stefanos Triaridis, MD; Miltiadis Tsalighopoulos, MD From the Department of Otolaryngology, Aristotle University of Thessaloniki,
More informationP0 Antigen Detection in Sudden Hearing Loss and Ménière s Disease: A New Diagnostic Marker?
Acta Otolaryngol 2004; 124: 1145/1148 P0 Antigen Detection in Sudden Hearing Loss and Ménière s Disease: A New Diagnostic Marker? DESIDERIO PASSALI 1, VALERIO DAMIANI 1, RENZO MORA 2, FRANCESCO MARIA PASSALI
More informationHearing Outcome of Low-tone Compared to High-tone Sudden Sensorineural Hearing Loss
THIEME Original Research Hearing Outcome of Low-tone Compared to High-tone Sudden Sensorineural Hearing Loss George Psillas 1 Aikaterini Rizou 1 Dimitrios Rachovitsas 1 Gabriel Tsiropoulos 1 Jiannis Constantinidis
More informationLabyrinthectomy and Vestibular Neurectomy for Intractable Vertiginous Symptoms
184 Systematic Review The Surgical Management of Vestibular Disorders THIEME Labyrinthectomy and Vestibular Neurectomy for Intractable Vertiginous Symptoms Alfredo Vega Alarcón 1,2 Lourdes Olivia Vales
More informationIntratympanic steroid injection as a salvage treatment for sudden sensorineural hearing loss
The Journal of Laryngology & Otology, 1 of 6. JLO (1984) Limited, 2014 doi:10.1017/s0022215114002710 MAIN ARTICLE Intratympanic steroid injection as a salvage treatment for sudden sensorineural hearing
More informationIntratympanic Therapies for Menière s Disease
Curr Otorhinolaryngol Rep (2014) 2:137 143 DOI 10.1007/s40136-014-0055-8 MENIERE S DISEASE (L LUSTIG, SECTION EDITOR) Intratympanic Therapies for Menière s Disease Matthew W. Miller Yuri Agrawal Published
More informationClinical Indicators Useful in Predicting Response to the Medical Management of Meniere s Disease
The Laryngoscope Lippincott Williams & Wilkins, Inc., Philadelphia 2000 The American Laryngological, Rhinological and Otological Society, Inc. Clinical Indicators Useful in Predicting Response to the Medical
More informationJ.P.S. Bakshi Manual of Ear, Nose and Throat
J.P.S. Bakshi Manual of Ear, Nose and Throat Reading excerpt Manual of Ear, Nose and Throat of J.P.S. Bakshi Publisher: B. Jain http://www.narayana-publishers.com/b5603 Copying excerpts is not permitted.
More informationWhat could be reffered to as dizziness by the patient?
What could be reffered to as dizziness by the patient? Rotational vertigo Sense of instability Ataxia of gait Disturbance of vision Loss of contact with surroundings Nausea Loss of memory Loss of confidence
More informationDizziness: Neurological Aspect
Dizziness: Neurological Aspect..! E-mail: somtia@kku.ac.th http://epilepsy.kku.ac.th Features between peripheral and central vertigo 1. Peripheral Central 2.! " # $ " Imbalance Mild-moderate Severe 3.!
More informationmet het oog op evenwicht
met het oog op evenwicht Herman Kingma, Department of ORL, Maastricht University Medical Centre Faculty of Biomedical Technology, Technical University Eindhoven problems in patients with dizziness and
More informationLearning Objectives. Bilateral Vestibular Loss. Bilateral Vestibular Loss. Diagnosis of vestibulotoxicity is usually easy
Learning Objectives Bilateral Vestibular Loss Learn how to recognize bilateral vestibular loss Learn treatment of bilateral vestibular loss Timothy C. Hain, M.D. Northwestern University Medical School
More informationSuperior Semicircular Canal Dehiscence Mimicking Otosclerotic Hearing Loss
Arnold W, Häusler R (eds): Otosclerosis and Stapes Surgery. Adv Otorhinolaryngol. Basel, Karger, 7, vol 65, pp 137 145 Superior Semicircular Canal Dehiscence Mimicking Otosclerotic Hearing Loss Saumil
More informationYoung Hyo Kim, Hong Lyeol Lee, Kyu-Sung Kim, Hoseok Choi, Jeong Seok Choi, Seung Ho Shin
Int. Adv. Otol. 2011; 7:(1) 91-95 ORIGINAL ARTICLE Young Hyo Kim, Hong Lyeol Lee, Kyu-Sung Kim, Hoseok Choi, Jeong Seok Choi, Seung Ho Shin Department of Otorhinolaryngology-Head & Neck Surgery, Inha University
More informationThe Dizziness Handicap Inventory and Its Relationship with Vestibular Diseases
Int. Adv. Otol. 2012; 8:(1) 69-77 ORIGINAL ARTICLE The Dizziness Handicap Inventory and Its Relationship with Vestibular Diseases Mi Joo Kim, Kyu-Sung Kim, Yeon Hee Joo, Soo Young Park, Gyu Cheol Han Department
More informationIndications and contra-indications of auditory brainstem implants. Systematic review and illustrative cases
Manuscript: Authors: Journal: Indications and contra-indications of auditory brainstem implants. Systematic review and illustrative cases Merkus P (p.merkus@vumc.nl), Di Lella F, Di Trapani G, Pasanisi
More informationEast and Central African Journal of Surgery Volume 15 Number 2. July/August 2010.
Effect of Spinal Anaesthesia on Hearing Threshold A.O. Lasisi 1, H.O. Lawal 2, A.A. Sanusi 3, 1 Department of Otorhinolaryngolgy, University of Ibadan. 2 Department of Otorhinolaryngology, University College
More informationVertigo. Done by : Njoud Alrasheed. Reviewed by :Hadeel B. Alsulami. Correction File
Vertigo Objectives: To know anatomy of balance organs Physiology of balance Relevant history in dizzy patients Classification of vertigo Common peripheral causes of vertigo, clinical features, investigation
More informationVia Transmastoid Approach. Mitul Chaitan Bhatt. Maharashtra University Miraj India
ISSN: 2250-0359 Volume 6 Issue 1 2016 Evaluation Of Patients Of Traumatic Facial Palsy Treated By Facial Nerve Decompression Via Transmastoid Approach Mitul Chaitan Bhatt Maharashtra University Miraj India
More informationClinical Characteristics of Labyrinthine Concussion
online ML Comm ORIGINAL ARTICLE Korean J Audiol 2013;17:13-17 pissn 2092-9862 / eissn 2093-3797 http://dx.doi.org/10.7874/kja.2013.17.1.13 Clinical Characteristics of Labyrinthine Concussion Mi Suk Choi,
More informationRecent Advances in Medical Otology-Neurotology
INVITED REVIEWS Recent Advances in Medical Otology-Neurotology Mohamed Hamid, M.D., PhD, EE From the Cleveland Hearing & Balance Center, Cleveland, OH, USA. Correspondence: Mohamed Hamid, M.D, PhD The
More informationOcular Vestibular Evoked Myogenic Potentials to Air Conducted Tone Bursts in Patients with Unilateral Definite Ménière s Disease
Int. Adv. Otol. 2013; 9:(2) 180-185 ORIGINAL AERICLE Ocular Vestibular Evoked Myogenic Potentials to Air Conducted Tone Bursts in Patients with Unilateral Definite Ménière s Disease Mohamed M Abdeltawwab
More informationMRI Inner Ear Imaging and Tone Burst Electrocochleography in the Diagnosis of
Otology & Neurotology 36:1109Y1114 Ó 2015, Otology & Neurotology, Inc. MRI Inner Ear Imaging and Tone Burst Electrocochleography in the Diagnosis of Ménière s Disease * Jeremy Hornibrook, *Edward Flook,
More informationVIDEONYSTAGMOGRAPHY (VNG) TUTORIAL
VIDEONYSTAGMOGRAPHY (VNG) TUTORIAL Expected Outcomes Site of lesion localization: Determine which sensory input, motor output, and/or neural pathways may be responsible for the patient s reported symptoms
More informationIntratympanic Steroid Treatment as a Primary Therapy in Idiopathic Sudden Sensorineural Hearing Loss
Int. Adv. Otol. 2009; 5:(3) 334-339 ORIGINAL ARTICLE Intratympanic Steroid Treatment as a Primary Therapy in Idiopathic Sudden Sensorineural Hearing Loss Ljiljana Cvorovic, Mile Strbac, Milan B. Jovanovic,
More informationTenotomy of the middle ear muscles causes a dramatic reduction in vertigo attacks and improves audiological function in definite Meniere s disease
Acta Oto-Laryngologica, ; Early Online, 7 ORIGINAL ARTICLE Tenotomy of the middle ear muscles causes a dramatic reduction in vertigo attacks and improves audiological function in definite Meniere s disease
More informationVertigo. Tunde Magyar MD, PhD
Vertigo Tunde Magyar MD, PhD What could be reffered to as dizziness by the patient? Rotational vertigo Sense of instability Ataxia of gait Disturbance of vision Loss of contact with surroundings Nausea
More informationOtotoxicity Monitoring: The M. D. Anderson Experience. James H. Hall, Jr., M.A., CCC-A Hilary H. Arnaud, Au.D., CCC-A
Ototoxicity Monitoring: The M. D. Anderson Experience James H. Hall, Jr., M.A., CCC-A Hilary H. Arnaud, Au.D., CCC-A Objectives Overview and presentation of cancer in adult and pediatric patients Discuss
More informationCoding with Confidence:
Coding with Confidence: CPT, HCPCS, Modifiers & ICD-10 Alyssa Needleman, PhD Nova Southeastern University August 4, 2017 Coding Considerations: Procedure (CPT, HCPCs) and Diagnosis (ICD-10) Code for test/procedure(s)
More informationUNILATERAL SUDDEN SENSORINEURAL HEARING LOSS AFTER GENERAL ANESTHESIA
UNILATERAL SUDDEN SENSORINEURAL HEARING LOSS AFTER GENERAL ANESTHESIA Hakan Emirkadi, MD Department of Anesthesiology Golcuk Military Hospital Kocaeli / TURKEY Background-Sudden Sensorineural Hearing Loss
More informationThree-Dimensional Eye-Movement Responses to Surface Galvanic Vestibular Stimulation in Normal Subjects and in Patients
Three-Dimensional Eye-Movement Responses to Surface Galvanic Vestibular Stimulation in Normal Subjects and in Patients A Comparison H.G. MACDOUGALL, a A.E. BRIZUELA, a I.S. CURTHOYS, a AND G.M. HALMAGYI
More informationStudy of brainstem evoked response audiometry in sensorineural hearing deafness- A hospital based study
Original Research Article Study of brainstem evoked response audiometry in sensorineural hearing deafness- A hospital based study Swapnil Gosavi 1,*, James Thomas 2, G.D. Mahajan 3 1 Lecturer, MGM Medical
More informationHISAKUNI FUKUOKA 1, YUTAKA TAKUMI 1, KEITA TSUKADA 1, MAIKO MIYAGAWA 1, TOMOHIRO OGUCHI 1, HITOSHI UEDA 2, MASUMI KADOYA 2 & SHIN-ICHI USAMI 1
Acta Oto-Laryngologica, 2012; 132: 141 145 ORIGINAL ARTICLE Comparison of the diagnostic value of 3 T MRI after intratympanic injection of GBCA, electrocochleography, and the glycerol test in patients
More informationFukuda Stepping Test: Sensitivity and Specificity
Fukuda Stepping Test: Sensitivity and Specificity Julie A. Honaker University of Nebraska at Lincoln, jhonaker2@unl.edu Neil T. Shepard Mayo Clinic, shepard.neil@mayo.edu Includes Fukuda Stepping Test
More informationA two-week rotating schedule with some minor variability based on hospital/or scheduling
Goals and Objectives for the Otolaryngology-Head & Neck Surgery on Otology and Neurotology Rotation PGY4 St Joseph s Healthcare and Hamilton General site (3 four-week rotational blocks) Overview During
More informationHearing loss and fluctuating hearing levels in X-linked hypophosphataemic osteomalacia
The Journal of Laryngology & Otology (2009), 123, 136 140. # 2008 JLO (1984) Limited doi:10.1017/s0022215107001636 Clinical Record Hearing loss and fluctuating hearing levels in X-linked hypophosphataemic
More informationDIZZINESS Varieties. : Fainting, hypotension : Rotatory, spinning. : Muscular incoordination : Collapse without LOC: ELH : Disturbed awareness
DIZZINESS Varieties head Syncope Vertigo Dysequilibrium Ataxia Drop attacks Confusion Panic Attacks Non-organic : Fainting, hypotension : Rotatory, spinning : Unsteadiness on moving : Muscular incoordination
More informationSudden sensorineural hearing loss (SSNHL) was
Main Article Intratympanic Methylprednisolone Injection as First Line Therapy for Idiopathic Sudden Sensorineural Hearing Loss Mukul Patar, 1 Rupanjita Sangma 1 ABSTRACT Introduction Steroid therapy is
More informationTriple Semicircular Canal Occlusion in Guinea Pigs with Endolymphatic Hydrops
Otology & Neurotology 27:78 85 Ó 2005, Otology & Neurotology, Inc. Triple Semicircular Canal Occlusion in Guinea Pigs with Endolymphatic Hydrops *Shankai Yin, *Dongzhen Yu, *Manna Li, and Jian Wang *Department
More informationControl of eye movement
Control of eye movement Third Nerve Palsy Eye down and out Trochlear Nerve Palsy Note: Right eye Instead of intorsion and depression action of superior oblique See extorsion and elevation Observe how
More informationVestibular Neuritis With Minimal Canal Paresis: Characteristics and Clinical Implication
Original Article Clinical and Experimental Otorhinolaryngology Vol. 10, No. 2: 148-152, June 2017 http://dx.doi.org/10.21053/ceo.2016.00948 pissn 1976-8710 eissn 2005-0720 Vestibular Neuritis With Minimal
More informationBenign Paroxysmal Positional Vertigo Prevalence in Meniere s Disease: Is Meniere s Disease a Predisposing Factor?
Caspian Journal of Neurological Sciences http://cjns.gums.ac.ir Benign Paroxysmal Positional Vertigo Prevalence in Meniere s Disease: Is Meniere s Disease a Predisposing Factor? Motasaddi-Zarandi Masoud
More informationﺎﻨﺘﻤﻠﻋ ﺎﻣ ﻻا ﺎﻨﻟ ﻢﻠﻋ ﻻ ﻚﻧﺎﺤﺒﺳ اﻮﻟﺎﻗ ﻢﻴﻜﺤﻟا ﻢﻴﻠﻌﻟا ﺖﻧأ ﻚﻧا ﻢﻴﻈﻌﻟا ﷲا قﺪﺻ HEARING LOSS
قالوا سبحانك لا علم لنا الا ما علمتنا انك أنت العليم الحكيم صدق االله العظيم HEARING LOSS 1 Hearing loss: Deviation from normal hearing in one or both ears. Hearing handicap: This term refers to total
More informationUpdate '08: Vestibular and Balance Rehabilitation Therapy
Update '08: Vestibular and Balance Rehabilitation Therapy In Context with Surgery Medicine & Diet Symptoms of Dizziness Dizziness non-specific term; encompasses any and all of the specific symptoms: Vertigo
More informationOTOLOGY. 1. BRIEF DESCRIPTION OF OTOLOGIC TRAINING Rotations that include otologic training are a component of each of the four years of training.
OTOLOGY 1. BRIEF DESCRIPTION OF OTOLOGIC TRAINING Rotations that include otologic training are a component of each of the four years of training. Longwood Rotation PGY-2 through PGY-5 years o Clinic experience
More informationAudiology (Clinical Applications)
(Clinical Applications) Sasan Dabiri, M.D. Assistant Professor Department of Otorhinolaryngology Head & Neck Surgery Amir A lam hospital Tehran University of Medical Sciences Last Updated in February 2015
More informationSECONDARY ENDOLYMPHATIC HYDROPS
SECONDARY ENDOLYMPHATIC HYDROPS By Susan Pesznecker, RN, with the Vestibular Disorders Association. Updates by Jeremy Hinton, DPT. Endolymphatic hydrops is a disorder of the inner ear and can affect the
More informationCochlear Implant, Bone Anchored Hearing Aids, and Auditory Brainstem Implant
Origination: 06/23/08 Revised: 10/15/16 Annual Review: 11/10/16 Purpose: To provide cochlear implant, bone anchored hearing aids, and auditory brainstem implant guidelines for the Medical Department staff
More informationCochlear Implant Impedance Fluctuation in Ménière s Disease: A Case Study
Otology & Neurotology xx:xx xx ß 2016, Otology & Neurotology, Inc. Cochlear Implant Impedance Fluctuation in Ménière s Disease: A Case Study Celene McNeill and Kate Eykamp Healthy Hearing and Balance Care,
More informationVESTIBULAR FUNCTION TESTING
VESTIBULAR FUNCTION TESTING Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices
More information